Japanese institute develops bone replacement:
This article was originally published in Clinica
A new bone replacement material with the same strength and elasticity as human bone has been developed by the National Institute for Research in Inorganic Material in Japan. The bioresorbable material is composed of calcium phosphate bonded to polylactic-acid and the Tokyo Medical and Dental University cooperated in a dog study that proved the material's nontoxicity. Human studies are expected to begin within three years, reports Japan Chemical Week (August 29th).
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.